[RESULTS] There was no significant between-group difference in the rate of the composite primary end point ( 99 patients [ 14.3 % ] in the RIPC group and 101 [ 14.6 % ] in the sham-RIPC group , P = 0.89 ) or of any of the individual components : death ( 9 patients [ 1.3 % ] and 4 [ 0.6 % ] , respectively ; P = 0.21 ) , myocardial infarction ( 47 [ 6.8 % ] and 63 [ 9.1 % ] , P = 0.12 ) , stroke ( 14 [ 2.0 % ] and 15 [ 2.2 % ] , P = 0.79 ) , and acute renal failure ( 42 [ 6.1 % ] and 35 [ 5.1 % ] , P = 0.45 ) .